EVALUATION OF ANTIBIOTIC SENSITIVITY TEST RESULTS IN CLINICAL ISOLATES FROM VARIOUS ICU AT TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i9.45325Keywords:
Antibiotic sensitivity test, clinical isolates, ICUAbstract
Objective: The objectives of this study were to study bacteriological profile of clinical isolates, to study Antibiotic sensitivity patterns of isolates from various intensive care unit (ICU), and to provide Antibiotic sensitivity pattern to clinicians.
Methods: Different samples were received from all ICU from which different microorganisms grown by culture. Identification of microorganisms done by different biochemical reactions and antibiotic sensitivity testing done by manual Kirby disk diffusion method as standard manual protocol.
Results: In the present our study, Acinetobater is more prevalent that is 28% followed by Escherichia coli (22%), Pseudomonas spp (18%), and Klebsiella spp (17%). Acinetobacter species was highest in Neonatal ICU (25%) and Medical ICU (40%), while E. coli was highest in Pediatric ICU (39%) and Surgical ICU (39%), Pseudomonas spp. (28%) was highest in Idaho Central Credit Union patients. Most effective drugs are Levofloxacin, Imipenem, Piperacillintazobactam, and Amikacin.
Discussion and Conclusion: Antimicrobial resistance is emerging problem worldwide especially in ICU. Hence, it is very important to know resistant pattern and to formulate antibiogram of antibiotics for better management care of patient in all clinical set up, which may help to patient escalation and de-escalation of antibiotics.
Downloads
References
PPaterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-86.
Prabaker K, Weinstein RA. Trends in antimicrobial resistance in intensive care units in the United States. Curr Opin Crit Care 2011;17:472-9.
Humphries R. Performance Standards for Antimicrobial Susceptibility Testing, M100. 31st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.
Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9.
Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, NISC Comparative Sequencing Program Group. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4:148-16.
de Kraker M, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, et al. Burden of antimicrobial resistance in European hospitals: Excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2011;66:398-407.
Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin 2006;22:255-71.
Bradford PA. Extended spectrum β-lactamases in 21st century: Characterization, epidemiology and detection of this important resistant threat. Clin Microbiol Rev 2001;14:933-51.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Mannu Jain, rachna patel, Chinmay Luhar
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
